Scholar Rock announced its experimental add-on treatment for spinal muscular atrophy significantly improved motor function ...
Liquidia’s stock $LQDA rose about 10% on Monday following a win in the US Supreme Court for its treprostinil inhalation ...
Novo Nordisk and Mylan Pharmaceuticals, now part of Viatris, have settled their patent dispute over Novo’s blockbuster ...
AstraZeneca is strengthening its cardiovascular disease pipeline with a $100 million upfront deal for a lipid-targeting drug ...
Kezar Life Sciences’ autoimmune drug candidate, zetomipzomib, has been put on hold by the FDA after the company said last ...
Upstream Bio, a mid-stage respiratory drug developer, and CAMP4 Therapeutics, a Phase 1 regulatory RNA startup, have unveiled ...
The news that Pfizer has an activist isn’t a surprise. For the last few months at Endpoints News, we’ve been asking which ...
Many drug price proposals from candidates and Congress won't have much effect, analysis finds
Want to lower drug prices? Good luck. In a new report released Friday, the nonpartisan Congressional Budget Office (CBO) detailed how many of the campaign proposals mentioned by presidential nominees ...
Global investment manager Oaktree is out with its third life sciences-dedicated special purpose acquisition company after ...
The activist investor Starboard Value has taken a stake in Pfizer, according to media reports, following the drugmaker's months of lackluster results as it came out of the pandemic and sought the next ...
The European Medicines Agency is looking more closely at medicines used to treat hair loss and a condition caused by an ...
Kurma Partners has closed the first part of its latest biotech-focused fund, following a pair of M&A exits for drug ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback